A mutation in the SEPN1 selenocysteine redefinition element (SRE) reduces selenocysteine incorporation and leads to SEPN1-related myopathy.

Source:http://linkedlifedata.com/resource/pubmed/id/19067361

Download in:

View as

General Info

PMID
19067361